Development of a DNA-MVA/HIVA vaccine for Kenya
- 5 February 2002
- Vol. 20 (15) , 1995-1998
- https://doi.org/10.1016/s0264-410x(02)00085-3
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA VaccinationScience, 2000
- Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infectionAIDS, 2000
- Characterization of HIV-1-specific T-helper cells in acute and chronic infectionImmunology Letters, 1999
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytesCurrent Biology, 1998
- Human Immunodeficiency Virus Type 1 (HIV‐1)‐Specific T Cell Responses Correlate with Control of Acute HIV‐1 Infection in MacaquesThe Journal of Infectious Diseases, 1997
- Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of InfectionScience, 1996
- Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaquesNature Medicine, 1995
- Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionNature, 1991